Stage IA3 Patient with EGFR Exon 19 Deletion Alteration and High-risk DetermaRx Result
Stage IA3 Patient with EGFR Exon 19 Deletion Alteration and High-risk DetermaRx Result
The panel discusses the sequence of chemotherapy and targeted therapy for a stage IA3 patient who presents with an EGFR exon 19 del alteration and a high-risk DetermaRx result.
